anxiety on tirzepatide & Anxiety: Mental Health Effects Explained Can tirzepatide (Zepbound) cause anxiety?

FDA approval for Retatrutide as a pharmaceutical product is projected for 2026 to 2027, so prescription access through traditional channels remains a year or more away

PlexusDx provides weekly check-ins to track progress

Based on these results, the FDA approved Wegovy for cardiovascular risk reduction in March 2024 making it the first weight-loss medication approved to prevent cardiovascular events

Ozempic and Mounjaro are now facing rolling shortages and supply problems in Australia as a result of global demand and widespread off-label use for weight loss

Borvinskaia EV et al

Note that the milligram threshold the article prints for that therapeutic dose does not correspond to a marketed strength, so treat the number cautiously